Tag: ANDA approval

Bioequivalence Studies: What the FDA Requires Generic Drug Manufacturers to Prove

Finnegan O'Sullivan Jan 23 3

The FDA requires generic drug manufacturers to prove bioequivalence through rigorous clinical studies that show their product delivers the same active ingredient at the same rate as the brand-name version. This ensures safety, effectiveness, and cost savings for patients.

More Detail